pmoUmin. p < O.Wl). In the basal period urinary 6.Keto-prostaglsndin-F,. was significantly higher @ < 0.05) in group B than in group A, no differences being found in the remamiog parameters, including plasma renin activity (group A, 9.7 f 2.6 vs. group B, 12.0 f 3.9 @ml per h) and urinary sodium output (group A, 30.1 f 10.6 vs. group B, 11.8 + 3.5pmoV mm). In summary, our results suggest that renal prostacyclin metabolism influences renal response to fumsemide in drrhotic patients.
The mechanisms underlying the dcvelapment of amtemia in some cirrhotic pattents with asdtcs undergoingsustained furosemide therapy have not been fully defined (t-6). Although furosemide inducts volume depletion and angiotensin II generation that can justify azotemia in some cases (5.6), profound impairments in renal function and renal plasma floe have been demonstrated immediately after a single dose of furosemide in patients in which these two alterations wire absent (17). These complications cannot be predicted from clinical or analytical data and they seem to be unrelated to the degree of hyperreninism or to the status of renal function before diuretic chatlenge (7) . Furthermore, recen! data indicate that prostaglandio-(PG) E, and thromboxane A, exert little or no influence on changes in renal function and renal hemodynamics observed in cirrhotics with nscitcs immediately af- 
